Toxoplasma IgM ELISA Kit

Toxoplasma gondii (T. gondii) is a parasite that infects a wide range of warm-blooded animals, including humans. Infection occurs mostly through swallowing contaminated food or water, as well as pregnant women passing the parasite to their fetuses. While T. gondii infection is typically asymptomatic or moderate in immunocompetent persons, it can cause serious difficulties in pregnant women and immunocompromised people. IgM antibody detection is essential for the diagnosis of early-stage T. gondii infection. After infection, IgM antibodies usually start to show up 1-2 weeks later and then progressively go away over several weeks to months. A positive result usually implies a recent acute illness, as IgM antibodies are transitory. However, there are limitations to IgM antibody detection. IgM antibodies can last for months or even years following the original infection, which may cause false-positive tests, particularly in expectant mothers. In immunocompromised patients, IgM antibody production may be reduced or delayed, lowering the accuracy of identifying T. gondii infection simply through IgM antibody. To improve diagnostic accuracy in T. gondii infection, IgM antibody detection is frequently coupled with other procedures such as IgG antibody testing, IgG avidity testing, and polymerase chain reaction (PCR).

Figure 1. Lifecycle of Toxoplasma gondii (Source: Sullivan WJ, et al., 2012)

T. gondii infection during pregnancy, especially vertical transfer from mother to fetus, is one of the most serious types of infection. The impact of infection on the fetus increases with early gestational age; nevertheless, the chance of serious consequences, such as miscarriage, stillbirth, and congenital abnormalities, reduces as gestational age grows. Early infections frequently lead to more serious consequences, such as central nervous system damage and eye abnormalities. Pregnancy-related infections in the first trimester are generally low risk, but they carry a high risk of serious fetal abnormalities or miscarriage. Since organ systems are still growing in the early stages of embryonic development, infection with T. gondii can harm developing tissues permanently. T. gondii infection during the second trimester is relatively prevalent. At this point, the placental barrier has matured, making it simpler for the parasite to get through and infect the fetus. Infection can cause prenatal growth restriction, central nervous system developmental problems, and congenital toxoplasmosis. Central nervous system damage, in particular, can cause intellectual developmental delays, epilepsy, and other neurological disorders. Infection during the third trimester poses the greatest risk, but the fetus's chances of developing severe problems are slim. Nonetheless, the newborn may have no evident signs at birth but acquire symptoms of congenital toxoplasmosis in the months or years that follow, such as vision impairment, hearing loss, and intellectual incapacity.

In immunocompetent people, acquired T. gondii infection is frequently asymptomatic or causes only moderate flu-like symptoms like fever, tiredness, and muscular aches. Following infection, the body generates specialized IgM and IgG antibodies to combat T. gondii invasion. Acute T. gondii infection is usually induced by consuming contaminated food or drink. Upon infection, the immune system responds quickly by manufacturing IgM antibodies to fight the parasite's early spread. In most situations, acute infection is self-limiting, with symptoms clearing up within a few weeks even without specific treatment. The chance of contracting T. gondii infection is considerably higher in patients with impaired immune systems. Due to immune system deficiencies or suppression, these patients may be unable to successfully clear the initial infection or control the parasite during chronic infection, which can result in repeated acute toxoplasmosis or severe consequences such as encephalitis or pneumonia. Following the first infection, T. gondii often enters a chronic phase of infection during which the parasite proliferates and forms cysts in organs like the brain and muscles. Long-lasting, these cysts usually don't cause noticeable symptoms in people with healthy immune systems. However, latent T. gondii cysts can reactivate and cause serious clinical symptoms such as toxoplasmic encephalitis in immunocompromised people, like AIDS patients or organ transplant recipients receiving immunosuppressive medication.

Toxoplasma IgM Detection Kit
Toxoplasmosis IgM ELISA